pembrolizumab

pembrolizumab (KEYTRUDA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

KEYTRUDA is a marketed brand name for pembrolizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.

pembrolizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.